6 reports

  • HEPATITIS C THERAPEUTICS MARKET, RISK FACTORS FOR FIBROSIS PROGRESSION, 2016
  • 2.7.2 CHRONIC STAGE

Factors accelerating liver fibrosis progression include older age at the time of infection, excess alcohol consumption, cigarette smoking and iron overload.

  • Hepatitis
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • Roche Group
  • HEPATITIS C THERAPEUTICS MARKET, RISK FACTORS FOR FIBROSIS
  • 4.6 Disease Progression

FACTORS ACCELERATING LIVER FIBROSIS PROGRESSION INCLUDE OLDER AGE AT THE TIME OF INFECTION, EXCESS ALCOHOL CONSUMPTION, CIGARETTE SMOKING AND IRON OVERLOAD.

  • Hepatitis
  • World
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.

Overall, it is believed that cigarette smoking causes approximately ##% of all cancer deaths in the US.

  • Hepatitis
  • World
  • Market Size
  • Juno Therapeutics Inc.
  • Merck & Co., Inc.

EACH PARTY, THROUGH ITS REPRESENTATIVES, SHALL HAVE ONE (##) VOTE ON THE JSC AND EACH SUBCOMMITTEE.

  • Hepatitis
  • AbbVie Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • RISK FACTORS AND COMORBIDITIES FOR HCC

Epidemiology BE DUE TO MEN BEING MORE LIKELY TO BE INFECTED WITH HBV AND HCV, TO CONSUME MORE ALCOHOL, TO SMOKE CIGARETTES, AND TO HAVE INCREASED IRON STORES (EL-SERAG AND RUDOLPH, 2007).

  • Hepatitis
  • Celsion Corporation
  • Eli Lilly & Co.
  • GlobalData's company
  • ThermoDox® group

THE IMPACT OF CHARACTERISTICS OF CIGARETTE SMOKING ON URINARY TRACT CANCER RISK: A META-ANALYSIS OF EPIDEMIOLOGIC STUDIES.

  • Cell Therapy
  • Hepatitis
  • Company
  • Demand
  • Product Initiative